Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis

Circulation

Volumn 119, Issue 5, 2009, Pages 671-679

  Kalantar Zadeh, Kamyar ^a,b,c   Regidor, Deborah L ^a,b   Kovesdy, Csaba P ^d   Van Wyck, David ^e,f   Bunnapradist, Suphamai ^c   Horwich, Tamara B ^c   Fonarow, Gregg C ^c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e DAVITA INC   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cardiovascular death; Heart failure; Obesity; Renal dialysis; Ultrafiltration

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; FLUID RETENTION; HEART DEATH; HEMODIALYSIS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; WEIGHT GAIN; AGED; BLOOD VOLUME; BODY FLUID; CHRONIC KIDNEY FAILURE; EDEMA; HEART FAILURE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; RISK FACTOR; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BLOOD VOLUME; BODY FLUIDS; EDEMA; FEMALE; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK FACTORS; UNITED STATES; WEIGHT GAIN;

EID: 61549089295     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.807362     Document Type: Article

References (40)

1. Katzarski KS. Monitoring of blood volume during haemodialysis treatment of acute renal and multiple organ failures. Nephrol Dial Transplant. 1996;11(suppl 8):20-23.
2. Kraemer M, Rode C, Wizemann V. Detection limit of methods to assess fluid status changes in dialysis patients. Kidney Int. 2006;69:1609-1620.
3. Charra B, Laurent G, Chazot C, Calemard E, Terrat JC, Vanel T, Jean G, Ruffet M. Clinical assessment of dry weight. Nephrol Dial Transplant. 1996;11(suppl 2):16-19.
4. Kazory A, Ross EA. Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective. Circulation. 2008;117:975-983.
5. Kalantar-Zadeh K, Abbott KC, Kronenberg F, Anker SD, Horwich TB, Fonarow GC. Epidemiology of dialysis patients and heart failure patients. Semin Nephrol. 2006;26:118-133.
6. Kalantar-Zadeh K, Anker SD, Horwich TB, Fonarow GC. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol. 2008;101:S89-S103.
7. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008;155:883-889.
8. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, Kovesdy CP, Younessi H, Anker SD, Morley JE. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care. 2007;10:433-442.
9. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004;43:1439-1444.
10. Kalantar-Zadeh K, Kovesdy CP, Derose SF, Horwich TB, Fonarow GC. Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol. 2007;3:493-506.
11. Horwich TB, Fonarow GC. Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS. Semin Dial. 2007;20:549-553.
12. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension. 2005;45:811-817.
13. Kilpatrick RD, McAllister CJ, Kovesdy CP, Derose SF, Kopple JD, Kalantar-Zadeh K. Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol. 2007;18: 293-303.
14. Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, McAllister CJ, Whellan D, Sharma K. A1C and survival in maintenance hemodialysis patients. Diabetes Care. 2007;30:1049-1055.
15. Shinaberger CS, Kilpatrick RD, Regidor DL, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K. Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis. 2006;48:37-49.
16. Longenecker JC, Coresh J, Klag MJ, Levey AS, Martin AA, Fink NE, Powe NR. Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study: Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol. 2000;11:520-529.
17. Rodriguez HJ, Domenici R, Diroll A, Goykhman I. Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line. Kidney Int. 2005;68:854-861.
18. Cotter G, Felker GM, Adams KF, Milo-Cotter O, O'Connor CM. The pathophysiology of acute heart failure: is it all about fluid accumulation? Am Heart J. 2008;155:9-18.
19. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007-2018.
20. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577-585.
21. Vaz Perez A, Anker SD, Dietz R, Rauchhaus M. Are diuretics overused in the treatment of chronic heart failure? Nat Clin Pract Cardiovasc Med. 2008;5:238-239.
22. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J Am Coll Cardiol. 2007;50: 1973-1980.
23. Weber KT. Aldosterone in congestive heart failure. N Engl J Med. 2001;345:1689-1697.
24. Sackner-Bernstein JD. Management of diuretic-refractory, volume-overloaded patients with acutely decompensated heart failure. Curr Cardiol Rep. 2005;7:204-210.
25. Sharp J, Wild MR, Gumley AI, Deighan CJ. A cognitive behavioral group approach to enhance adherence to hemodialysis fluid restrictions: a randomized controlled trial. Am J Kidney Dis. 2005;45:1046-1057.
26. Pace RC. Fluid management in patients on hemodialysis. Nephrol Nurs J. 2007;34:557-559.
27. Stevenson LW, Tillisch JH, Hamilton M, Luu M, Chelimsky-Fallick C, Moriguchi J, Kobashigawa J, Waiden J. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol. 1990;66:1348-1354.
28. United States Renal Data System. United States Renal Data System 2006 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Am J Kidney Din. 2007;49:1-296.
29. von Haehling S, Horwich TB, Fonarow GC, Anker SD. Tipping the scale: heart failure, body mass index, and prognosis. Circulation. 2007;116: 588-590.
30. von Haehling S, Doehner W, Anker SD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res. 2007;73:298-309.
31. Niethammer M, Sieber M, von Haehling S, Anker SD, Munzel T, Horstick G, Genth-Zotz S. Inflammatory pathways in patients with heart failure and preserved ejection fraction. Int J Cardiol. 2008;129:111-117.
32. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007;153:74-81.
33. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevinho-Becerra A, Wanner C. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391-398.
34. Banerjee D, Ma JZ, Collins AJ, Herzog CA. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol. 2007;2:1186-1190.
35. Bonnefont-Rousselot D, Mahmoudi A, Mougenot N, Varoquaux O, Le Nahour G, Fouret P, Lechat P. Catecholamine effects on cardiac remodelling, oxidative stress and fibrosis in experimental heart failure. Redox Rep. 2002;7:145-151.
36. Foster KR, Lukaski HC. Whole-body impedance: what does it measure? Am J Clin Nutr. 1996;64:388S-396S.
37. Ganion V, Rhodes M, Stadler RW. Intrathoracic impedance to monitor heart failure status: a comparison of two methods in a chronic heart failure dog model. Congest Heart Fail. 2005;11:177-181, 211.
38. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant. 2005;20:1880-1888.
39. Kalantar-Zadeh K, Rodriguez RA, Humphreys MH. Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant. 2004;19:141-149.
40. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis. 2003;42:761-773.